This combination approach also augmented the ratio of CD8+/CD4+ T cells in lymph tissues adjacent to tumor sites at mouse mammary glands, which is considered an important marker of immunological defense against tumor cell dissemination (61). The gene discussed is CD8A; the disease is neoplasm.